Nova Mentis Life Science Corp. (NOVA.CN)
CAD 0.01
(N/A%)
CAD 0.01
(N/A%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 CAD | 69.82% |
| 2022 | -0.03 CAD | -25.57% |
| 2021 | -0.02 CAD | 97.48% |
| 2020 | -0.87 CAD | -173900.0% |
| 2019 | -0.00 CAD | 99.58% |
| 2018 | -0.12 CAD | -43.37% |
| 2017 | -0.08 CAD | 44.2% |
| 2016 | -0.15 CAD | -93.8% |
| 2015 | -0.08 CAD | 79.63% |
| 2014 | -0.38 CAD | -426.32% |
| 2013 | -0.07 CAD | 96.7% |
| 2012 | -2.19 CAD | -44.08% |
| 2011 | -1.52 CAD | 48.47% |
| 2010 | -2.95 CAD | 23.38% |
| 2009 | -3.85 CAD | -93.47% |
| 2008 | -1.99 CAD | 16.74% |
| 2007 | -2.39 CAD | -168.54% |
| 2006 | -0.89 CAD | -71.15% |
| 2005 | -0.52 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.00 CAD | 40.0% |
| 2024 Q1 | -0.00 CAD | 28.57% |
| 2023 Q2 | -0.00 CAD | 41.67% |
| 2023 Q1 | -0.00 CAD | 78.95% |
| 2023 Q4 | -0.00 CAD | -7.69% |
| 2023 Q3 | -0.00 CAD | 38.1% |
| 2023 FY | - CAD | 69.82% |
| 2022 Q4 | -0.02 CAD | -714.29% |
| 2022 FY | - CAD | -25.57% |
| 2022 Q1 | -0.01 CAD | -166.67% |
| 2022 Q2 | -0.00 CAD | 62.5% |
| 2022 Q3 | -0.00 CAD | 0.0% |
| 2021 Q4 | -0.00 CAD | 83.33% |
| 2021 FY | - CAD | 97.48% |
| 2021 Q3 | -0.01 CAD | -231.58% |
| 2021 Q2 | -0.00 CAD | 32.14% |
| 2021 Q1 | -0.01 CAD | 96.0% |
| 2020 Q4 | -0.14 CAD | -1438.46% |
| 2020 Q1 | -0.01 CAD | 26.92% |
| 2020 FY | - CAD | -173900.0% |
| 2020 Q2 | -0.19 CAD | -3233.33% |
| 2020 Q3 | -0.01 CAD | 95.21% |
| 2019 Q3 | -0.01 CAD | 27.7% |
| 2019 Q2 | -0.01 CAD | -40.95% |
| 2019 Q1 | -0.01 CAD | 41.01% |
| 2019 Q4 | -0.01 CAD | 27.1% |
| 2019 FY | - CAD | 99.58% |
| 2018 Q2 | -0.01 CAD | 91.26% |
| 2018 Q3 | -0.03 CAD | -283.58% |
| 2018 FY | - CAD | -43.37% |
| 2018 Q1 | -0.08 CAD | -160.0% |
| 2018 Q4 | -0.02 CAD | 30.74% |
| 2017 Q3 | -0.02 CAD | -33.54% |
| 2017 FY | - CAD | 44.2% |
| 2017 Q2 | -0.02 CAD | -23.44% |
| 2017 Q1 | -0.01 CAD | 83.36% |
| 2017 Q4 | -0.03 CAD | -39.81% |
| 2016 Q3 | -0.02 CAD | 6.21% |
| 2016 Q1 | -0.01 CAD | 64.18% |
| 2016 FY | - CAD | -93.8% |
| 2016 Q2 | -0.02 CAD | -123.61% |
| 2016 Q4 | -0.08 CAD | -409.27% |
| 2015 FY | - CAD | 79.63% |
| 2015 Q1 | -0.02 CAD | 90.14% |
| 2015 Q2 | -0.01 CAD | 33.64% |
| 2015 Q3 | -0.02 CAD | -45.83% |
| 2015 Q4 | -0.02 CAD | 4.29% |
| 2014 Q1 | -0.02 CAD | 20.79% |
| 2014 Q4 | -0.22 CAD | -820.5% |
| 2014 FY | - CAD | -426.32% |
| 2014 Q3 | -0.02 CAD | 12.77% |
| 2014 Q2 | -0.03 CAD | -71.25% |
| 2013 Q1 | -0.02 CAD | 99.06% |
| 2013 FY | - CAD | 96.7% |
| 2013 Q2 | -0.01 CAD | 60.8% |
| 2013 Q4 | -0.02 CAD | 18.55% |
| 2013 Q3 | -0.02 CAD | -259.42% |
| 2012 Q1 | -0.06 CAD | 92.99% |
| 2012 FY | - CAD | -44.08% |
| 2012 Q3 | -0.07 CAD | -77.81% |
| 2012 Q4 | -1.88 CAD | -2597.27% |
| 2012 Q2 | -0.04 CAD | 30.99% |
| 2011 Q2 | -0.28 CAD | -12.0% |
| 2011 Q1 | -0.25 CAD | 68.75% |
| 2011 Q3 | -0.11 CAD | 60.71% |
| 2011 FY | - CAD | 48.47% |
| 2011 Q4 | -0.81 CAD | -636.36% |
| 2010 Q3 | -0.37 CAD | -76.19% |
| 2010 Q1 | -2.87 CAD | -293.15% |
| 2010 Q4 | -0.80 CAD | -116.22% |
| 2010 Q2 | -0.21 CAD | 92.68% |
| 2010 FY | - CAD | 23.38% |
| 2009 Q4 | -0.73 CAD | 18.89% |
| 2009 FY | - CAD | -93.47% |
| 2009 Q3 | -0.90 CAD | 7.22% |
| 2009 Q2 | -0.97 CAD | 46.11% |
| 2009 Q1 | -1.80 CAD | -1300.0% |
| 2008 Q2 | -0.82 CAD | -272.73% |
| 2008 Q3 | -1.12 CAD | -36.59% |
| 2008 FY | - CAD | 16.74% |
| 2008 Q1 | -0.22 CAD | 78.0% |
| 2008 Q4 | 0.15 CAD | 113.39% |
| 2007 Q4 | -1.00 CAD | -112.77% |
| 2007 Q1 | -1.03 CAD | -139.53% |
| 2007 Q3 | -0.47 CAD | -2.17% |
| 2007 Q2 | -0.46 CAD | 55.34% |
| 2007 FY | - CAD | -168.54% |
| 2006 Q3 | -0.14 CAD | -7.69% |
| 2006 FY | - CAD | -71.15% |
| 2006 Q1 | -0.13 CAD | 0.0% |
| 2006 Q4 | -0.43 CAD | -207.14% |
| 2006 Q2 | -0.13 CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -0.45 CAD | 98.156% |
| Asep Medical Holdings Inc | -0.13 CAD | 93.615% |
| BetterLife Pharma Inc. | -0.03 CAD | 68.561% |
| BioVaxys Technology Corp. | -0.06 CAD | 85.515% |
| ChitogenX Inc. | -0.02 CAD | 61.033% |
| Rapid Dose Therapeutics Corp. | -0.04 CAD | 79.756% |
| Defence Therapeutics Inc. | -0.30 CAD | 97.233% |
| Entheon Biomedical Corp. | -0.05 CAD | 83.661% |
| Gemina Laboratories Ltd. | -0.07 CAD | 88.472% |
| Glow Lifetech Corp. | -0.03 CAD | 71.181% |
| Lexston Life Sciences Corp. | -0.02 CAD | 63.913% |
| Pharmala Biotech Holdings Inc. | -0.01 CAD | 9.783% |
| Doseology Sciences Inc. | -0.08 CAD | 89.586% |
| MYND Life Sciences Inc. | -0.03 CAD | 74.143% |
| PharmaTher Holdings Ltd. | -0.04 CAD | 76.487% |
| PreveCeutical Medical Inc. | -0.00 CAD | -245.833% |
| Telescope Innovations Corp. | -0.12 CAD | 93.083% |